Healthcare provider profile · identity verified

Christopher D Cotton, MD

Allopathic & Osteopathic Physicians|General Practice · DENVER CITY, TX · NPI 1841271681

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Christopher D Cotton, MD received $29.03 in general payments during 2025 across 2 reported records.

Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 172 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 60 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$29.03

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$29.03	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$29.03	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$29.03	2	2025
Source payment records 2025-05-14 · Lilly USA, LLC · $14.59 · Open Payments source 2025-08-25 · Lilly USA, LLC · $14.44 · Open Payments source
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$29.03	2	2025
Source payment records 2025-05-14 · Lilly USA, LLC · $14.59 · Open Payments source 2025-08-25 · Lilly USA, LLC · $14.44 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
MOUNJARO mounjaro	2025	Mounjaro	2024	49	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	172	37
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	49	12
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	60	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	928	164
Amlodipine Besylate	Amlodipine Besylate	531	118
Gabapentin	Gabapentin	447	105
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	430	74
Atorvastatin Calcium	Atorvastatin Calcium	428	101
Losartan Potassium	Losartan Potassium	425	95
Pantoprazole Sodium	Pantoprazole Sodium	420	94
Pioglitazone Hcl	Pioglitazone Hcl	366	72
Pravastatin Sodium	Pravastatin Sodium	325	69
Lisinopril	Lisinopril	322	72
Metformin Hcl	Metformin Hcl	281	66
Rosuvastatin Calcium	Rosuvastatin Calcium	278	58
Potassium Chloride	Potassium Chloride	256	63
Metoprolol Succinate	Metoprolol Succinate	254	73
Metformin Hcl Er	Metformin Hcl	245	65
Tamsulosin Hcl	Tamsulosin Hcl	238	60
Montelukast Sodium	Montelukast Sodium	229	41
Tramadol Hcl	Tramadol Hcl	222	45
Furosemide	Furosemide	219	49
Eliquis	Apixaban	180	29
Jardiance	Empagliflozin	172	37
Clopidogrel	Clopidogrel Bisulfate	167	40
Omeprazole	Omeprazole	167	45
Duloxetine Hcl	Duloxetine Hcl	158	34
Allopurinol	Allopurinol	146	39
Donepezil Hcl	Donepezil Hcl	143	23
Celecoxib	Celecoxib	142	37
Memantine Hcl	Memantine Hcl	138	24
Glimepiride	Glimepiride	132	31
Escitalopram Oxalate	Escitalopram Oxalate	126	28
Meloxicam	Meloxicam	125	42
Mirtazapine	Mirtazapine	125	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	124	31
Hydrochlorothiazide	Hydrochlorothiazide	123	30
Farxiga	Dapagliflozin Propanediol	121	26
Metoprolol Tartrate	Metoprolol Tartrate	118	30
Carvedilol	Carvedilol	117	26
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	112	30
Atenolol	Atenolol	111	23
Clonazepam	Clonazepam	106	24
Tizanidine Hcl	Tizanidine Hcl	101	34
Trazodone Hcl	Trazodone Hcl	99	19
Pregabalin	Pregabalin	98	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	97	30
Famotidine	Famotidine	91	30
Fluoxetine Hcl	Fluoxetine Hcl	87	18
Methocarbamol	Methocarbamol	87	34
Acetaminophen-Codeine	Acetaminophen With Codeine	84	22
Olmesartan Medoxomil	Olmesartan Medoxomil	84	17
Cefuroxime	Cefuroxime Axetil	81	56
Albuterol Sulfate Hfa	Albuterol Sulfate	79	35
Alendronate Sodium	Alendronate Sodium	79	15
Prednisone	Prednisone	76	26
Torsemide	Torsemide	75	19
Zolpidem Tartrate	Zolpidem Tartrate	72	13
Irbesartan	Irbesartan	71	21
Estradiol	Estradiol	70	16
Ramipril	Ramipril	70	13
Alprazolam	Alprazolam	67	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	62	suppressed
Buspirone Hcl	Buspirone Hcl	61	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	61	12
Fluticasone Propionate	Fluticasone Propionate	61	25
Januvia	Sitagliptin Phosphate	60	11
Trulicity	Dulaglutide	60	suppressed
Sertraline Hcl	Sertraline Hcl	59	16
Telmisartan	Telmisartan	59	suppressed
Azithromycin	Azithromycin	56	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	19
Azelastine Hcl	Azelastine Hcl	55	21
Finasteride	Finasteride	55	15
Tradjenta	Linagliptin	53	12
Clonidine Hcl	Clonidine Hcl	52	14
Divalproex Sodium	Divalproex Sodium	51	suppressed
Nabumetone	Nabumetone	51	13
Simvastatin	Simvastatin	51	16
Triamcinolone Acetonide	Triamcinolone Acetonide	51	18
Mounjaro	Tirzepatide	49	12
Glyxambi	Empagliflozin/Linagliptin	47	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	13
Ozempic	Semaglutide	45	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	44	11
Trijardy Xr	Empaglifloz/Linaglip/Metformin	44	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	43	12
Baclofen	Baclofen	42	suppressed
Synthroid	Levothyroxine Sodium	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Trospium Chloride	Trospium Chloride	39	suppressed
Bumetanide	Bumetanide	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Levofloxacin	Levofloxacin	38	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	12
Spironolactone	Spironolactone	37	13
Tresiba Flextouch U-100	Insulin Degludec	37	12
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Propranolol Hcl Er	Propranolol Hcl	36	suppressed
Lactulose	Lactulose	35	11
Nifedipine Er	Nifedipine	35	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Fluconazole	Fluconazole	34	28
Olanzapine	Olanzapine	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	34	suppressed
Diazepam	Diazepam	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	27
Janumet	Sitagliptin Phos/Metformin Hcl	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Aripiprazole	Aripiprazole	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	18
Raloxifene Hcl	Raloxifene Hcl	31	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	30	suppressed
Ondansetron Odt	Ondansetron	29	13
Glipizide Er	Glipizide	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Morphine Sulfate Er	Morphine Sulfate	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Promethazine Hcl	Promethazine Hcl	27	12
Sulfasalazine	Sulfasalazine	27	suppressed
Cefdinir	Cefdinir	26	19
Dropsafe Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	13
Naproxen	Naproxen	26	suppressed
Nystatin	Nystatin	26	18
Brilinta	Ticagrelor	25	suppressed
Ceftriaxone	Ceftriaxone Sodium	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	13
Metoclopramide Hcl	Metoclopramide Hcl	25	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	25	17
Valsartan	Valsartan	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Dexamethasone	Dexamethasone	24	21
Ezetimibe	Ezetimibe	24	suppressed
Fentanyl	Fentanyl	24	suppressed
Risperidone	Risperidone	24	suppressed
Levemir Flexpen	Insulin Detemir	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	22	suppressed
Glipizide	Glipizide	22	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	22	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	22	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Erythromycin	Erythromycin Base	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Topiramate	Topiramate	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Colchicine	Colchicine	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Minoxidil	Minoxidil	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	18
Felodipine Er	Felodipine	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Metolazone	Metolazone	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	17	suppressed
Flurbiprofen	Flurbiprofen	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Lidocaine Hcl	Lidocaine Hcl	17	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	16	16
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	15
Clonidine	Clonidine	16	suppressed
Constulose	Lactulose	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Eszopiclone	Eszopiclone	15	suppressed
Gemtesa	Vibegron	15	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Theophylline Er	Theophylline Anhydrous	15	suppressed
Verapamil Sr	Verapamil Hcl	15	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Warfarin Sodium	Warfarin Sodium	14	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Norethindrone	Norethindrone	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Risedronate Sodium	Risedronate Sodium	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Comfort Ez Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	11
Ursodiol	Ursodiol	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Acarbose	Acarbose	11	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Linzess	Linaclotide	11	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$29.03 · 2 records	Lilly USA, LLC	MOUNJARO, ZEPBOUND	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Mounjaro play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error